GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,448.00p
   
  • Change Today:
      22.50p
  • 52 Week High: 1,774.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,100.23m
  • Volume: 7,237,685
  • Market Cap: £59,371m
  • RiskGrade: 129
  • Beta: 0.00

Regulatory News

Transaction in Own Shares 27-May-2025 07:00 RNS
positive CHMP opinion on Blenrep in EU 23-May-2025 12:16 RNS
Transaction in Own Shares 23-May-2025 07:00 RNS
FDA approves Nucala COPD indication 23-May-2025 07:00 RNS
Transaction in Own Shares 22-May-2025 07:00 RNS
Transaction in Own Shares 21-May-2025 07:00 RNS
Director/PDMR Shareholding 20-May-2025 15:30 RNS
Transaction in Own Shares 20-May-2025 07:00 RNS
Blenrep for 2L+ multiple myeloma approved in Japan 19-May-2025 07:00 RNS
Transaction in Own Shares 19-May-2025 07:00 RNS
Transaction in Own Shares 16-May-2025 07:00 RNS
Transaction in Own Shares 15-May-2025 07:00 RNS
GSK to acquire efimosfermin 14-May-2025 07:00 RNS
Transaction in Own Shares 14-May-2025 07:00 RNS
Director/PDMR Shareholding 13-May-2025 15:30 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,448.00p
Change Today 22.50p
% Change 1.58 %
52 Week High 1,774.50
52 Week Low 1,264.00
Volume 7,237,685
Shares Issued 4,100.23m
Market Cap £59,371m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.05% below the market average44.05% below the market average44.05% below the market average44.05% below the market average44.05% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Price Trend
13.86% above the market average13.86% above the market average13.86% above the market average13.86% above the market average13.86% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Income
74.90% above the market average74.90% above the market average74.90% above the market average74.90% above the market average74.90% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 27-May-2025

Time Volume / Share Price
16:05 0 @ 1,451.00p
16:01 1 @ 1,452.00p
15:52 1 @ 1,454.00p
15:13 5 @ 1,452.50p
14:56 10 @ 1,453.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page